PTC Therapeutics Inc. buy Truist Financial Co.
Start price
16.08.23
/
50%
€36.60
Target price
16.08.24
€59.68
Performance (%)
-7.65%
Price
27.05.24
€33.80
Summary
This prediction is currently active. With a performance of -7.65%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 16.08.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 8.333% | 8.333% |
iShares Core DAX® | 0.192% | 3.121% |
iShares Nasdaq 100 | 1.245% | 5.051% |
iShares Nikkei 225® | -0.992% | 1.101% |
iShares S&P 500 | 0.154% | 2.864% |
Comments by Truist_Financial_Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $65.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€42.12
18.09.24
18.09.24
35.96%
27.05.24
27.05.24